LUX-Dx TRENDS Evaluates Diagnostics Sensors in Heart Failure Patients Receiving Boston Scientific's Investigational ICM System.
A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 557 participants.
Also called NCT04790344
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose diagnostic
- Phase
- Not applicable
- Enrolled
- 557 participants
- Sponsor
- Registry
-
NCT04790344
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- United States
- Registry status
- Completed
Technical summary
Registry record NCT04790344. Allocation not applicable; no masking; primary purpose diagnostic. Start 2021-03-20 (actual); primary completion 2026-07-27 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- LUX-Dx TRENDS Evaluates Diagnostics Sensors in Heart Failure Patients Receiving Boston Scientific's Investigational ICM System.
- Condition
- Heart Failure
- Intervention (Device)
- Investigational LUX-Dx ICM Implant
- Lead sponsor
- Boston Scientific Corporation
Record details
- Record id
cardio:ct-nct04790344- Content hash
cef36db8cddc09d2916e81388e705196ced2fdf66c7192edf3940261aa9a89e8